Ovarian cancer is highly prevalent and accounts for high mortality rate among cancers relating to female reproductive system (1). As per the Global Cancer Statistics (2020), every year almost 24,000 women are diagnosed with ovarian cancer. Most of the patients are diagnosed at advanced stages. Unfortunately, it is noted that 70% of patients treated with standard Platinum chemotherapy have recurrence of ovarian cancer within 18 to 28 months (1, 2). Challenges with recurrent ov